Literature DB >> 11072593

Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis.

P Macchioni1, L Boiardi, B Casali, D Nicoli, E Farnetti, C Salvarani.   

Abstract

AIMS: Rheumatoid arthritis (RA) has a wide range of clinical expressions which probably reflects different genetic backgrounds. Intercellular adhesion molecule-1 (ICAM-1) plays an important role in the inflammatory synovial activity in RA. The aim of this study was to examine the potential associations of ICAM-1 gene polymorphisms with RA and its severity.
METHODS: Seventy-eight seropositive Italian RA patients with erosive disease entered the study. Radiographs of hands and feet 5 years after the diagnosis were available for 68 patients and were evaluated for the number of eroded joints. We obtained an erosive score for each patient by counting the number of joints with at least one erosion. Patients in the upper part of the distribution over the median were considered as fast eroders (FE) and the others as slow eroders (SE). Patients' records were also evaluated for the presence of extra-articular features. 228 healthy subjects of the same ethnic origin were selected as a control group. All of the RA patients and controls were genotyped by polymerase chain reaction and allele-specific oligonucleotide techniques for ICAM-1 polymorphisms G/R at codon 241 (exon 4) and E/K at codon 469 (exon 6).
RESULTS: The carriage rate of allele R241 was significantly higher in RA patients than in healthy controls (12.8% versus 5.7%, p = 0.039; odds ratio: 2.4 [95% CI 1.02 to 5.79]). The allele frequencies and carriage rate of the E 469 gene did not differ significantly between RA patients and the control group. When we compared the control group with the patients with more or less severe disease (presence or absence of extra-articular features, SE and FE) we found that only the group of patients with the more favourable course maintained a significant difference in the carriage rate of R241 (16.7 vs 5.7%, p = 0.009 for patients without extra-articular features and 18.9 vs 5.7%, p = 0.004 for SE patients).
CONCLUSION: Our preliminary findings show that G/R 241 polymorphism of ICAM-1 is associated with RA, and that this confers a reduced risk of extra-articular manifestations and is associated with a slow rate of joint destruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072593

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.

Authors:  B R Yacyshyn; A Schievella; K L Sewell; J A Tami
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

2.  Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Mária Bucová; Daniela Čopíková-Cudráková; Jozef Michalík; Karin Gmitterová; Daniel Čierny; Milan Buc; Vladimíra Ďurmanová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-27       Impact factor: 2.099

3.  Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations.

Authors:  Mahmoud R Hussein; Nehal A Fathi; Azza M Ezz El-Din; Hewayda I Hassan; Fatemah Abdullah; Eman Al-Hakeem; Eman Abo Backer
Journal:  Pathol Oncol Res       Date:  2008-04-08       Impact factor: 3.201

4.  ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas.

Authors:  Regislaine Valéria Burim; Silvia Aparecida Teixeira; Benedicto Oscar Colli; Fernanda Maris Peria; Luis Fernando Tirapelli; Suely Kazue Nagahashi Marie; Suzana Maria Fleury Malheiros; Sueli Mieko Oba-Shinjo; Alberto Alain Gabbai; Paulo Andrade Lotufo; Carlos Gilberto Carlotti-Júnior
Journal:  Clin Exp Med       Date:  2009-03-21       Impact factor: 3.984

5.  Association between two single base polymorphisms of intercellular adhesion molecule 1 gene and inflammatory bowel disease.

Authors:  Manijeh Habibi; Nosratllah Naderi; Alma Farnood; Hedieh Balaii; Tahereh Dadaei; Shohreh Almasi; Homayoun Zojaji; Hamid Asadzadeh Aghdae; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.